Hugh Paul ONeill

Insider Reports History

Location
Hazelwood, MO
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh Paul ONeill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keenova Therapeutics plc EVP, Chief Operations Officer Ordinary Shares 1,802 $159,928 $88.75 01 Jan 2026 Direct
Keenova Therapeutics plc EVP, Chief Operations Officer Restricted Stock Units 48,913 25 Feb 2026 Direct

Insider Reports Filed by Hugh Paul ONeill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465926020850-oneill-hugh-paul-2026-02-25 Keenova Therapeutics plc 25 Feb 2026 1 $0 4 EVP, Chief Operations Officer 26 Feb 2026, 21:01
/report/000110465926000783-oneill-hugh-paul-2026-01-01 Keenova Therapeutics plc 01 Jan 2026 3 $0 4 EVP, Qual & Ops, Spec Brands 05 Jan 2026, 18:03
/report/000110465925073801-oneill-hugh-paul-2025-07-31 Mallinckrodt plc 31 Jul 2025 1 $0 4 EVP, Qual & Ops, Spec Brands 04 Aug 2025, 20:57
/report/000110465925000365-oneill-hugh-paul-2025-01-01 Mallinckrodt plc 01 Jan 2025 3 $0 4 EVP, Qual & Ops, Spec Brands 02 Jan 2025, 17:00
/report/000110465924033009-oneill-hugh-paul-2024-02-28 Mallinckrodt plc 28 Feb 2024 0 $0 3 EVP, Qual & Ops, Spec Brands 11 Mar 2024, 16:27